CIBC Private Wealth Group
RCUS icon

CIBC Private Wealth Group’s Arcus Biosciences RCUS Stock Holding History

CIBC Private Wealth Group’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$453 Buy
+19
New +$388 ﹤0.01% 3062
2018
Q2 		– Sell
-1,500
Closed -$23K – 2070
2018
Q1 		$23K Buy
+1,500
New +$25K ﹤0.01% 1359

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

CIBC Private Wealth Group's RCUS Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Arcus Biosciences (RCUS) in Q4 2025: 19 shares worth $453. The stake represents ﹤0.01% of the portfolio and ranks #3062 among its holdings. This is a return to the name: CIBC Private Wealth Group previously reported a position in RCUS as recently as Q1 2018.

CIBC Private Wealth Group first reported a position in RCUS in Q1 2018 and has held it in 2 quarters since. The position peaked at $23K in Q1 2018. 209 funds tracked by Wall St. Rank hold RCUS as of Q4 2025.

  • CIBC Private Wealth Group held 19 shares of Arcus Biosciences worth $453 as of Q4 2025.
  • Arcus Biosciences was a new CIBC Private Wealth Group position in Q4 2025.
  • Arcus Biosciences made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3062 holding.
  • CIBC Private Wealth Group first reported a position in Arcus Biosciences in Q1 2018 and has held it in 2 quarters since.
  • CIBC Private Wealth Group's Arcus Biosciences position peaked at $23K in Q1 2018.
  • 209 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.